Put patients first with bloodborne disease panel testing 

OnSite® Bloodborne Rapid Test Panels enable comprehensive early detection of bloodborne diseases, helping guide more effective care decisions – all in 15 minutes or less.  

Why OnSite®? 

• 15-minute results support same-day screening and treatment, reducing repeat clinic visits and helping more patients stay engaged in care. 

• Adaptable for both centralized labs and point-of-care use, advancing worldwide efforts to expand access to reliable testing and integrate bloodborne disease prevention, treatment, and surveillance programs. 

• Detect and differentiate multiple bloodborne infections with up to 100% sensitivity and specificity*, ensuring informed care decisions and ruling out co-infections that may complicate treatment. 

• Validated for use with blood donors and pregnant women* delivering safe and accurate results for vulnerable patients. 

• Shelf stable at 2-30°C for up to 24 months, reducing costs by omitting the need for cold-chain management. 

*Please refer to individual product inserts for specific cross-reactivity and interference data.